The data of Quan et al. provided the evidence that the binding of LINC02362 to miR-18a-5p served as a molecular sponge to modulate FDX1, which bolstered the sensitivity of hepatocellular carcinoma to oxaliplatin via cuproptosis (Quan et al., 2023). This evidence concerns the gene FDX1 and hepatocellular carcinoma.